Groundbreaking Gene Therapy Trials Offering Hope to Blind Patients
According to a new research report by RNCOS entitled, “Global Gene Therapy Market Outlook 2018”, the advancement of gene therapy for eye disorders is likely to prove to be one of the greatest medical advances in the coming years, as industry participants are increasingly strengthening the research-based approach to develop newer products. The treatment involves inserting a functional gene into the eye that restores vision without causing any harm to the neighboring cells.
View full press release